[PRESS RELEASE] – EDMONTON, Alberta, Sept. 18, 2025 – Aurora Hashish Inc., the Canadian-based main world clinical hashish corporate, introduced a five-year funding into operational upgrades at its EU-GMP production facility in Leuna, Germany. Construction on very best practices confirmed at Aurora’s Canadian amenities, those enhancements will build up flower expansion capability, product high quality and force price potency.
“This funding marks a vital milestone in our dedication to operational excellence and long-term expansion in Europe,” mentioned Alex Miller, govt vp of operations, science and provide chain at Aurora. “Those upgrades will support our provide chain resilience, enlarge our home features in EU-GMP qualified production, and place us to very best meet the rising call for for high quality clinical hashish in Europe with precision and potency.”
Aurora’s world production community upholds the easiest production requirements that might be followed on the German facility. With the function of maximizing cultivation quantity, the upgrades come with commissioning further develop rooms, new irrigation and lighting fixtures techniques in current rooms, and transitioning to hold dry and dry trim.
As considered one of most effective 3 authorized cultivation amenities within the nation, Aurora Leuna performs a pivotal function in supplying high quality, in the community grown clinical hashish to fulfill the wishes of Germany’s increasing affected person base. Aurora Leuna recently grows cultivars beneath the IndiMed logo, and this growth will permit the web site to develop further cultivars to be had from Aurora’s main genetics library. Through regularly making an investment in operational features, Aurora is very best situated to serve global markets on the easiest requirements.
